Applied Biosystems to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference.

FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Tuesday, February 5, 2008. The live webcast is scheduled to begin at 10:20 a.m. ET. Mark Stevenson, President and Chief Operating Officer for Applied Biosystems, will provide an overview of the business and then answer questions from a Merrill Lynch analyst and conference participants.

Interested parties may access the live webcast and replay by visiting the Investors section of the Applied Biosystems web site at http://ir.appliedbiosystems.com or the Investors & Media section of the Applera web site at www.applera.com. It is suggested that participants access the webcast 15 minutes before the start of the live webcast. A replay of the webcast will be archived on the Presentations page of the Investors section of each website.

About Applera Corporation and Applied Biosystems

Applera Corporation consists of two operating groups. Applied Biosystems serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries and develop new pharmaceuticals. Applied Biosystems' products also serve the needs of some markets outside of life science research, which we refer to as "applied markets," such as the fields of: human identity testing (forensic and paternity testing); biosecurity, which refers to products needed in response to the threat of biological terrorism and other malicious, accidental, and natural biological dangers; and quality and safety testing, such as testing required for food and pharmaceutical manufacturing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of approximately $2.1 billion during fiscal 2007. The Celera Group is a diagnostics business delivering personalized disease management through a combination of products and services incorporating proprietary discoveries. Berkeley HeartLab, a subsidiary of Celera, offers services to predict cardiovascular disease risk and optimize patient management. Celera also commercializes a wide range of molecular diagnostic products through its strategic alliance with Abbott and has licensed other relevant diagnostic technologies developed to provide personalized disease management in cancer and liver diseases. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com. All information in this press release is as of the date of the release, and Applera does not undertake any duty to update this information unless required by law.

Copyright(c) 2008. Applera Corporation. All Rights Reserved. AB (Design), Applied Biosystems, Applera, and Celera are registered trademarks of Applera Corporation or its subsidiaries in the U.S. and/or certain other countries.